Form 8-K - Current report:
SEC Accession No. 0000849146-23-000020
Filing Date
2023-02-16
Accepted
2023-02-16 16:43:12
Documents
14
Period of Report
2023-02-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20230215.htm   iXBRL 8-K 37374
2 EX-16.1 wsrplfvnexhibit161toform.htm EX-16.1 1031
6 wsrplfvnexhibit161toform001.jpg GRAPHIC 50802
  Complete submission text file 0000849146-23-000020.txt   250022

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20230215.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20230215_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20230215_pre.xml EX-101.PRE 13064
8 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20230215_htm.xml XML 11238
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 23639046
SIC: 2834 Pharmaceutical Preparations